ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

MELD score < 18 rule out 28-day ACLF development among inpatients with hepatitis B-related previous compensated liver disease

Qi, Tingting; Zhu, Congyan; Wang, Jiapeng; Li, Beiling; Huang, Zuxiong; Zhu, Zhibin; Tu, Minghan; Deng, Guohong; Zheng, Xin; Huang, Yan; Meng, Zhongji; Wang, Xianbo; Qian, Zhiping; Li, Hai*; Gao, Yanhang; Liu, Feng; Shang, Jia; Shi, Yu; Lu, Xiaobo; Wang, Shaoyang; Chen, Jinjun*复旦大学; 广东医学院; 华中科技大学; 吉林大学; 南方医科大学; 山东大学; 上海交通大学; 浙江大学; 1
Journal of Viral Hepatitis2022-12DOI: 10.1111/jvh.13747
4阅读
引用收藏
分享

摘要

The acute-on-chronic liver failure (ACLF) development is highly dynamic. Currently, no satisfactory algorithm identifies patients with HBV at risk of this complication. The aim of the study was to characterize ACLF development in hospitalized HBV-related patients without previous decompensation and to test the performance of traditional prognostic models in ruling out ACLF development within 28 days on admission we conducted a cohort study. Two multi-center cohorts with hospitalized HBV-related previous compensated patients were analyzed. Performances of MELD, MELD-Na, CLIF-C AD, and CLIF-C ACLF-D in ruling out ACLF development within 28 days were compared and further validated by ROC analyses. In the derivation cohort (n = 892), there were 102 patients developed ACLF within 28 days, with profound systemic inflammatory levels and higher 28-day mortality rate (31.4% vs. 1.0%) than those without ACLF development. The MELD score (cut-off = 18) achieved acceptable missing rate (missed/total ACLF development) at 2.9%. In the validation cohort (n = 1656), the MELD score (<18) was able to rule out ACLF development within 28 days with missing rate at 3.0%. ACLF development within 28 days were both lower than 1% (0.6%, derivation cohort; 0.5%, validation cohort) in patients with MELD < 18. While in patients with MELD >= 18, 26.6% (99/372, derivation cohort) and 17.8% (130/732, validation cohort) developed into ACLF within 28 days, respectively. While MELD-Na score cut-off at 20 and CLIF-AD score cut-off at 42 did not have consistent performance in our two cohorts. MELD < 18 was able to safely rule out patients with ACLF development within 28 days in HBV-related patients without previous decompensation, which had a high 28-day mortality.

学科与关键词

关键词
ACLF developmentchronic hepatitis BCLIF-C ADMELD
相关
加载中…
  • New Algorithm Rules Out Acute-on-chronic Liver Failure Development within 28 Days from Acute Decompensation of Cirrhosis
    Tang, Xiaoting; Li, Hai; Deng, Guohong; Zheng, Xin; Wang, Xianbo; Huang, Yan; Gao, Yanhang; Meng, Zhongji; Qian, Zhiping; Liu, Feng; Lu, Xiaobo; Shi, Yu; Li, Beiling; Gu, Wenyi; Xiang, Xiaomei; Xiong, Yan; Hou, Yixin; Chen, Jun; Gao, Na; Luo, Sen; Ji, Liujuan; Li, Jing; Zheng, Rongjiong; Ren, Haotang; Chen, JinjunJournal of Clinical and Translational Hepatology, 2023, 11(3): 550-559.
  • Role of precipitants in transition of acute decompensation to acute-on-chronic liver failure in patients with HBV-related cirrhosis
    Wang, Tongyu; Tan, Wenting; Wang, Xianbo; Zheng, Xin; Huang, Yan; Li, Beiling; Meng, Zhongji; Gao, Yanhang; Qian, Zhiping; Liu, Feng; Lu, Xiaobo; Yan, Huadong; Zheng, Yubao; Zhang, Weituo; Yin, Shan; Gu, Wenyi; Zhang, Yan; Dong, Fuchen; Wei, Jianyi; Deng, Guohong; Xiang, Xiaomei; Zhou, Yi; Hou, Yixin; Zhang, Qun; Xiong, Shue; Liu, Jing; Long, Liyuan; Chen, Ruochan; Chen, Jinjun; Jiang, Xiuhua; Luo, Sen; Chen, Yuanyuan; Jiang, Chang; Zhao, Jinming; Ji, Liujuan; Mei, Xue; Li, Jing; Li, TaoJHEP REPORTS, 2022, 4(10): 100529.被引 7
  • Prognosis prediction performs better in patients with non-cirrhosis hepatitis B virus-related acute-on-chronic liver failure than those with cirrhosis
    Yu, Xia; Li, Hai; Tan, Wenting; Wang, Xianbo; Zheng, Xin; Huang, Yan; Li, Beiling; Meng, Zhongji; Gao, Yanhang; Qian, Zhiping; Liu, Feng; Lu, Xiaobo; Shang, Jia; Yan, Huadong; Zheng, Yubao; Zhang, Weituo; Yin, Shan; Gu, Wenyi; Deng, Guohong; Xiang, Xiaomei; Zhou, Yi; Hou, Yixin; Zhang, Qun; Xiong, Shue; Liu, Jing; Chen, Ruochan; Long, Liyuan; Chen, Jinjun; Jiang, Xiuhua; Luo, Sen; Chen, Yuanyuan; Jiang, Chang; Zhao, Jinming; Ji, Liujuan; Mei, Xue; Li, Jing; Li, Tao; Zheng, RongjiongFrontiers in Microbiology, 2022, 13: 1013439.被引 1
查看全部 →

发表信息

论文状态
公开发表
期刊
Journal of Viral Hepatitis
发表日期
2022-12
卷期
第 29 卷, 第 12 期
页码
1089-1098
DOI
10.1111/jvh.13747
语言
ENGLISH
期刊等级
2区
成果收录
SCIE
资助标注
National Science and Technology Major Project [2018ZX10723203, 2018ZX10302206]; National Key Research and Development Program of China [2017YFC0908100]; National Natural Science Foundation of China [82070650, 81670532]; Local Innovative and Research Teams Project of Guangdong Pearl River Talents Program [2017BT01S131]; Department of Science and Technology of Guangdong Province [2014B020228003, 2015B020226004]; Provincial Natural Science Foundation of Fujian [2020J011167]

作者

  • Q

    Qi, Tingting (第一作者)

    southern med univ

  • Z

    Zhu, Congyan

    zhuhai peoples hosp · southern med univ

查看全部 21 位作者收起作者
  • W

    Wang, Jiapeng

    tianjin first cent hosp · southern med univ

  • L

    Li, Beiling

    southern med univ

  • H

    Huang, Zuxiong

    fujian med univ

  • Z

    Zhu, Zhibin

    guangdong med coll

  • T

    Tu, Minghan

    southern med univ

  • D

    Deng, Guohong

    third mil med univ

  • Z

    Zheng, Xin

    huazhong univ sci & technol

  • H

    Huang, Yan

  • M

    Meng, Zhongji

    hubei univ med

  • W

    Wang, Xianbo

    beijing ditan hosp · capital med univ

  • Q

    Qian, Zhiping

    fudan univ

  • L

    Li, Hai (通讯)

    shanghai jiao tong univ · peoples armed police force

  • G

    Gao, Yanhang

    jilin univ

  • L

    Liu, Feng

    2 · shandong univ

  • S

    Shang, Jia

    henan prov peoples hosp

  • S

    Shi, Yu

    1 · zhejiang univ

  • L

    Lu, Xiaobo

    1 · xinjiang med univ

  • W

    Wang, Shaoyang

    fuzhou gen hosp nanjing mil command

  • C

    Chen, Jinjun (通讯)

    southern med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417